Compare ARK Genomic Revolution ETF (ARKG) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs SAP SE — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while SAP SE trades at $158 (market cap $182.93B). The key difference: SAP SE pays a 1.86% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, SAP SE nearer its low. Which is the better fit depends on your goals.
| ARKG | SAP | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $308.61 |
52-Week Low | $23.09 | $148.06 |
Market Cap | — | $182.93B |
Enterprise Value | — | $180.44B |
Dividend Yield | — | 1.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SAP trades at $157.86, down 0.38% on the day, amid a bearish technical signal but strong fundamental performance. The stock has beaten earnings expectations for three consecutive quarters, with Q2 2026 EPS expected at $2.05. Revenue grew to $36.80B in 2025, with a net income margin of 19.58%, while the company maintains robust cash flow from operations of $9.16B. Recent news highlights SAP's resolution of EU antitrust concerns and strategic focus on AI investments to drive future growth.
The outlook for SAP is positive based on solid fundamentals and analyst consensus, with a price target of $228.50 implying significant upside. However, risks include competitive pressures, execution of AI initiatives, and macroeconomic volatility. Investors should weigh the strong profitability and growth trajectory against near-term technical weakness and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
